Suchergebnisse - "Goel, Sanjay"

PubPharm (12)

1

Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Jiffry, J. | Thavornwatanayong, T. | Rao, D. | +8

2

Immune characterization of metastatic colorectal cancer patients post reovirus administration

enthalten in: BMC cancer | 2020

von Parakrama, R. | Fogel, E. | Chandy, C. | +5

3

A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

enthalten in: Investigational new drugs | 2014

von Ghamande, S. | Lin, C. | Cho, D. | +13

4

Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan

enthalten in: Oncotarget | 2014

von Maitra, R. | Seetharam, R. | Tesfa, L. | +5

5

A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

enthalten in: Investigational new drugs | 2013

von Ghamande, S. | Lin, C. | Cho, D. | +13

6

A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

enthalten in: Investigational new drugs | 2013

von Ghamande, S. | Lin, C. | Cho, D. | +13

7

A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

enthalten in: Investigational new drugs | 2013

von Ghamande, S. | Lin, C. | Cho, D. | +13

8

Therapeutic targeting of CPT-11 induced diarrhea : a case for prophylaxis

enthalten in: Current drug targets | 2013

von Swami, U. | Goel, S. | Mani, S.

9

Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies

enthalten in: Cancer | 2012

von Kurzrock, R. | Goel, S. | Wheler, J. | +11

10

Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers

enthalten in: Investigational new drugs | 2007

von Goel, S. | Desai, K. | Karri, S. | +9